|
Patient
|
Age (years)/sex
|
Response
|
Survival duration (months)
|
TS expression* before treatment
|
TS expression* after treatment
|
|---|
|
1
|
50/F
|
PD
|
4
|
4
|
11
|
|
2
|
70/M
|
PD
|
20
|
4
|
12
|
|
3
|
69/F
|
PD
|
17
|
5
|
21
|
|
4
|
61/M
|
PD
|
20
|
12
|
34
|
|
5
|
44/F
|
PD
|
27
|
15
|
47
|
|
6
|
53/M
|
PD
|
5
|
10
|
9
|
|
7
|
56/F
|
PD
|
9
|
23
|
ND
|
|
8
|
58/M
|
PD
|
7
|
14
|
ND
|
|
9
|
60/F
|
PD
|
13
|
15
|
ND
|
|
10
|
52/M
|
SD
|
11
|
9
|
14
|
|
11
|
79/M
|
SD
|
25
|
17
|
ND
|
|
12
|
49/F
|
SD
|
34
|
32
|
ND
|
|
13
|
63/M
|
SD
|
8
|
20
|
ND
|
|
14
|
56/F
|
SD
|
5
|
19
|
ND
|
|
15
|
51/F
|
PR
|
17
|
20
|
ND
|
|
16
|
65/M
|
PR
|
21
|
6
|
ND
|
|
17
|
55/M
|
PR
|
17
|
8
|
ND
|
|
18
|
70/M
|
PR
|
28
|
15
|
ND
|
|
19
|
73/F
|
PR
|
81
|
8
|
ND
|
|
20
|
65/M
|
CR
|
47
|
8
|
ND
|
- * This value is expressed in arbitrary units; F, female; M, male; PD, progression disease; SD, stable disease; PR, partial response; CR, complete response; ND, not determined.
